Investing.com -- Shares of Maia Biotechnology Inc (NYSE American:MAIA) climbed 3.4% today after the company reported encouraging survival data from its THIO-101 pivotal Phase 2 clinical trial. The ...

Ltd (NASDAQ:CYBR) declined by 2% today after the company announced its intention to offer $750 million of 0.00% Convertible Senior Notes due 2030 in a private offering to qualified institutional ...

Shares of Dr. Reddy’s Laboratories Ltd ADR (NYSE:RDY) climbed 3.1% in premarket trading today following the announcement of a collaboration and license agreement with Alvotech to co-develop, ...

Only a small share of British companies now see U.S. trade policy as a major concern, according to the Bank of England’s (BoE ...

Bernstein had previously a bearish view on the stock, with downgrading it on concerns around falling gross margins due to ...